AKT1 and hepatocellular carcinoma: Based on our findings as a whole, it is most likely that raloxifene and bazedoxifene reduce the TGF-α-induced migration of HCC-derived HuH7 cells mediated through inhibiting the AKT signaling pathway via ERβ.